DDR1

From WikiMD's Medical Encyclopedia

Revision as of 08:20, 17 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

DDR1[edit]

DDR1, also known as Discoidin Domain Receptor Tyrosine Kinase 1, is a type of protein encoded by the DDR1 gene in humans. It is a member of a novel subfamily of tyrosine kinase receptors with an extracellular domain homologous to Dictyostelium discoideum protein discoidin I in their extracellular region. The DDR1 protein is a receptor for collagen and plays a crucial role in various biological processes.

Structure[edit]

The DDR1 protein is a transmembrane receptor that is activated by collagen binding. It consists of a large extracellular region, a single transmembrane region, and a cytoplasmic region. The extracellular region contains a discoidin domain, which is responsible for binding to collagen. The cytoplasmic region contains a tyrosine kinase domain, which is responsible for the protein's enzymatic activity.

Function[edit]

DDR1 is involved in various cellular functions, including cell adhesion, cell migration, proliferation, and differentiation. It plays a crucial role in tissue repair, primarily through its involvement in the regulation of cell-matrix interactions. In addition, DDR1 has been implicated in the pathogenesis of several diseases, including cancer, fibrosis, and atherosclerosis.

Clinical significance[edit]

Alterations in the DDR1 gene have been associated with several types of cancer, including breast cancer, lung cancer, and brain cancer. Overexpression of DDR1 has been observed in many cancer types, suggesting that it may play a role in tumor progression. In addition, DDR1 has been implicated in the development of fibrosis, a condition characterized by excessive deposition of collagen in tissues.

Research[edit]

Research on DDR1 has focused on understanding its role in disease and developing targeted therapies. Several small molecule inhibitors of DDR1 have been developed and are currently being tested in preclinical studies. These inhibitors have the potential to be used as targeted therapies for diseases associated with DDR1 overexpression or mutation.

See also[edit]

References[edit]

<references />


Stub icon
   This article is a protein-related stub. You can help WikiMD by expanding it!




Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.